BioCentury
ARTICLE | Clinical News

Fanapt iloperidone regulatory update

January 11, 2016 8:00 AM UTC

EMA accepted for review an MAA for Fanaptum iloperidone to treat schizophrenia in adults. In 2013, Vanda withdrew an MAA for the serotonin (5-HT2) receptor and dopamine receptor antagonist after EMA’...